Prothena to Report Fourth Quarter and Full Year 2015 Financial Results and Host Webcast Conference Call on February 18
(Thomson Reuters ONE) -
DUBLIN, Ireland, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development and commercialization of novel protein immunotherapies,
announced today that it will report its fourth quarter and full year 2015
financial results on Thursday, February 18, 2016, after the close of the U.S.
financial markets. The announcement will be followed by a live audio webcast and
conference call at 4:30 PM ET.
The webcast will be made available on the Company's website
at www.prothena.com under the Investors tab in the Events and Presentations
section. Following the live audio webcast, a replay will be available on the
Company's website for at least 90 days.
To access the call via dial-in, please dial (877) 887-5215 (U.S. toll free) or
(315) 625-3069 (international) five minutes prior to the start time and refer to
conference ID number 33151950. A replay of the call will be available until
February 25, 2016 via dial-in at (855) 859-2056 (U.S. toll free) or (404)
537-3406 (international), Conference ID Number 33151950.
Separately, Prothena's presentation time at the upcoming Leerink Partners 5th
Annual Global Healthcare Conference on February 11, 2016 has changed. Prothena
will participate in a fireside chat at 9:20 AM ET in New York, NY. The event
will be webcast and available on the Company's website atwww.prothena.com under
the Investors tab in the Events and Presentations section.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology company focused
on the discovery, development and commercialization of novel protein
immunotherapies for the potential treatment of diseases that involve amyloid or
cell adhesion. The company is developing antibody-based product candidates that
target a number of potential indications including AL amyloidosis (NEOD001),
Parkinson's disease and other related synucleinopathies (PRX002), and psoriasis
and other inflammatory diseases (PRX003).
For more information, please visit the company's web site at www.prothena.com.
Contacts
Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Ellen Rose
650-922-2405, ellen.rose(at)prothena.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Prothena Corporation plc via GlobeNewswire
[HUG#1983576]
Unternehmensinformation / Kurzprofil:
Datum: 04.02.2016 - 22:05 Uhr
Sprache: Deutsch
News-ID 448880
Anzahl Zeichen: 3061
contact information:
Town:
DUBLIN
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 160 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prothena to Report Fourth Quarter and Full Year 2015 Financial Results and Host Webcast Conference Call on February 18"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
